5 Key Takeaways
-
1
Patients with glaucoma often have comorbid systemic and ophthalmic diseases that complicate monitoring and treatment.
-
2
Branch retinal artery occlusion (BRAO) can significantly affect the ability to assess glaucomatous damage in affected eyes.
-
3
The Spectralis OCT with GMPE software allows for detailed evaluation of retinal nerve fiber layer and neuroretinal rim in glaucoma patients.
-
4
Loss of ganglion cell layer thickness due to BRAO can hinder the monitoring of glaucoma progression in affected areas.
-
5
Evaluating the neuroretinal rim at the optic nerve head remains crucial for assessing glaucomatous damage in the presence of confounding factors.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


